JPRN-UMIN000002592
Recruiting
Phase 2
A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cell - Feasibility study of postoperative maintenance TS-1 chemotherapy and a biomarker study of CTC in NSCLC
DEPARTMENT OF THORACIC SURGERY, HYOGO COLLEGE OF MEDICINE0 sites40 target enrollmentOctober 7, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Completely resected pathologic stage II-IIIA non-small cell lung cancer
- Sponsor
- DEPARTMENT OF THORACIC SURGERY, HYOGO COLLEGE OF MEDICINE
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Active other malignant disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Feasibility study of a postoperative adjuvant chemotherapy which performs the maintenance therapy of TS-1 after CBDCA+TS-1 to the patients of pathological stage II-IIIA with completely resected non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000006351Escargot40
Recruiting
Not Applicable
Feasibility study of postoperative adjuvant therapy using S-1 after curative esophagectomy for esophageal cancerJPRN-jRCT1060220042Hirahara Noriyuki45
Completed
Phase 2
A phase II trial of postoperative adjuvant chemotherapy with carboplatin/ docetaxel for the patients completely resected Non Small Cell Lung Cancernon-small cell lung cancerJPRN-UMIN000002425niversity of Occupational and Environmental Health65
Completed
Phase 4
Evaluation of Effects of Postoperative Adjuvant Therapy with Anastrozole on Bone in Postmenopausal Women with Breast CancerHormone-responsive postmenopausal breast cancerJPRN-UMIN000000514Saitama Breast Cancer Clinical Study Group (SBCCSG)350
Completed
Not Applicable
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50